Retatrutide

20mg≥99.5% Purity

Retatrutide 20mg lyophilised powder for mid-range clinical protocols.

Request a Quote

Pricing available for qualified medical professionals, clinics, and distributors.

Enquire Now Download Monograph View FAQ

Mechanism of Action

Retatrutide is a triple agonist targeting GIP, GLP-1, and glucagon receptors.

Read the research

Clinical Benefits

Triple receptor agonist mechanism
Mid-range dosage for established protocols
Pharmaceutical-grade purity
Stable lyophilised formulation

Specifications

MechanismTriple agonist (GIP/GLP-1/Glucagon)

Purity≥99.5%

Dosage20mg per vial

Storage & Handling

Store at 2–8°C
Protect from light

Related Products

Lyophilised Powder

Retatrutide

10mg

Lyophilised Powder

Retatrutide

30mg

For professional medical use only. Not for retail sale to the general public. Pricing available on request for qualified medical institutions and distributors.